Compare Magnolia Oil & Gas Corporation Class A Common Stock (MGY) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Magnolia Oil & Gas Corporation Class A Common Stock vs Tenet Healthcare Corporation — how do they compare? Magnolia Oil & Gas Corporation Class A Common Stock trades at $24.9 (market cap $6.69B), while Tenet Healthcare Corporation trades at $277.39 (market cap $21.87B). The key difference: Tenet Healthcare Corporation is far larger — about 3.3× Magnolia Oil & Gas Corporation Class A Common Stock's market cap, and Magnolia Oil & Gas Corporation Class A Common Stock pays a 2.66% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Magnolia Oil & Gas Corporation Class A Common Stock for 0 Days and Tenet Healthcare Corporation for 16 Days on average.
| MGY | THC | |
|---|---|---|
Market Cap | $6.69B | $21.87B |
Volume | 2,677,107 | 717,275 |
Sector | Energy | Health |
52-Week High | $32.36 | $280.77 |
52-Week Low | $21.24 | $161.37 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $6.80B | $32.95B |
Dividend Yield | 2.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Magnolia Oil & Gas (MGY) trades at $25.11, up 2.66% with neutral technical signals. The company demonstrates strong fundamentals with a P/E of 10.97, net income margin of 28.77%, and consistent earnings beats. Recent WildFire Energy acquisition positions MGY for production doubling and significant free cash flow growth, with 2027 FCF projected over $1 billion. Analyst consensus remains strongly bullish with 66.7% buy ratings and $33.78 price target.
MGY presents compelling value with attractive valuation multiples and robust profitability metrics. The WildFire acquisition accelerates growth but introduces integration execution risk. Current price offers 35% upside to consensus target, though oil price volatility and operational execution remain key watchpoints for investors.
Tenet Healthcare (THC) trades at $266.91, down 0.69% on the day, with strong fundamental performance including three consecutive quarterly earnings beats. The stock maintains bullish technical signals with key support at $265 and resistance at $271. Revenue growth continues despite softer surgical volumes, driven by higher revenue per case and favorable service mix. Analyst consensus remains overwhelmingly positive with 81% buy ratings and a $283.36 price target representing 6% upside potential.
THC presents a compelling investment case with attractive valuation metrics (P/E 10.5, EV/EBITDA 5.91) and strong profitability (ROE 53.31%, net margin 9.9%). The company's expanding capital-return strategy is supported by robust cash flow, though growth investments and capital needs require monitoring. Key risks include execution challenges and healthcare regulatory uncertainty, but the fundamental outlook remains positive with expected revenue growth to $22.6B and net profit margin expansion to 9.89% in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Magnolia Oil & Gas Corporation Class A Common Stock
Magnolia Oil & Gas Corporation is an independent oil and gas exploration and production company operating in the Eagle Ford Shale and Austin Chalk formations of South Texas.
Read more on MGY →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
